Company History

Logo-Vaxinnate_286U1-300x89VaxInnate was founded in 2002 by Ruslan Medzhitov and Richard Flavell, both of Yale University and Howard Hughes Medical Institute and leaders in the field of innate immunity.

In 2004, the company expanded from its original New Haven, CT location and established a development team and corporate headquarters in Cranbury, NJ. Today, it occupies approximately 20,000 square feet of laboratory and office space, including molecular and cell biology labs, cell culture facilities, a protein pilot plant and analytical laboratory space.

VaxInnate has raised over $100 million to date and is backed by well-known venture capital firms, including HealthCare Ventures, Oxford Bioscience Partners LLC, CHL Medical Partners, New Leaf Venture Partners, Canaan Partners and The Wellcome Trust.